Quzhou Xin'an Development Co., Ltd. (SHA:600208)

Market Cap	34.80B
Revenue (ttm)	14.59B
Net Income (ttm)	1.07B
Shares Out	8.45B
EPS (ttm)	0.13
PE Ratio	32.69
Forward PE	16.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	171,702,605
Average Volume	217,626,777
Open	4.090
Previous Close	4.110
Day's Range	4.040 - 4.200
52-Week Range	1.600 - 4.200
Beta	0.70
RSI	80.92
Earnings Date	Aug 30, 2025

About Intercept Pharmaceuticals

Quzhou Xin'an Development Co., Ltd. engages in the real estate development, technology manufacturing, and financial service businesses in China. It develops commercial housing projects. The company was formerly known as Xinhu Zhongbao Co.,Ltd. and changed its name to Quzhou Xin'an Development Co., Ltd. in August 2023. The company was founded in 1993 and is based in Hangzhou, China.

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1993
• Employees: 761
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600208

Financial Performance

In 2024, Quzhou Xin'an Development's revenue was 16.49 billion, a decrease of -4.21% compared to the previous year's 17.21 billion. Earnings were 1.02 billion, a decrease of -37.74%.